Lipoprotein(a) Internalization in HepG2 Cells is Regulated by Proprotein Convertase Subtilisin Kexin Type 9 Through the Low-Density Lipoprotein Receptor

被引：0
|
作者：
Romagnuolo, Rocco
Seidah, Nabil G.
Koschinsky, Marlys L.
机构：
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2014年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A437
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Lipoprotein(a) Catabolism Is Regulated by Proprotein Convertase Subtilisin/Kexin Type 9 through the Low Density Lipoprotein Receptor
    Romagnuolo, Rocco
    Scipione, Corey A.
    Boffa, Michael B.
    Marcovina, Santica M.
    Seidah, Nabil G.
    Koschinsky, Marlys L.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (18) : 11649 - 11662
  • [2] Affinity and kinetics of proprotein convertase subtilisin/kexin type 9 binding to low-density lipoprotein receptors on HepG2 cells
    Mousavi, Seyed A.
    Berge, Knut E.
    Berg, Trond
    Leren, Trond P.
    FEBS JOURNAL, 2011, 278 (16) : 2938 - 2950
  • [3] Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin/kexin type 9
    Romagnuolo, Rocco
    Scipione, Corey A.
    Marcovina, Santica M.
    Gemin, Matthew
    Seidah, Nabil G.
    Boffa, Michael B.
    Koschinsky, Marlys L.
    PLOS ONE, 2017, 12 (07):
  • [4] Hypercholesterolemia, low density lipoprotein receptor and proprotein convertase subtilisin/kexin-type 9
    Gu, Hong-mei
    Zhang, Da-wei
    JOURNAL OF BIOMEDICAL RESEARCH, 2015, 29 (05): : 356 - 361
  • [5] Hypercholesterolemia,low density lipoprotein receptor and proprotein convertase subtilisin/kexin-type 9
    Hong-mei Gu
    Da-wei Zhang
    The Journal of Biomedical Research, 2015, 29 (05) : 356 - 361
  • [6] Clearance of Plasma Proprotein Convertase Subtilisin/Kexin 9 by Low-Density Lipoprotein Apheresis
    Duell, P. B.
    Dubuc, Genevieve
    Seidah, Nabil G.
    Davignon, Jean
    CIRCULATION RESEARCH, 2014, 115 (01) : E3 - E4
  • [7] Proprotein convertase subtilisin/kexin type 9, its variants and regulation of low-density lipoprotein cholesterol
    Wierzbicki, Anthony S.
    CURRENT OPINION IN LIPIDOLOGY, 2007, 18 (02) : 227 - 229
  • [8] Lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 inhibitors
    Julius U.
    Tselmin S.
    Schatz U.
    Fischer S.
    Bornstein S.R.
    Clinical Research in Cardiology Supplements, 2019, 14 (Suppl 1) : 45 - 50
  • [9] Lipoprotein(a) and inhibitors of proprotein convertase subtilisin/kexin type 9
    Kotani, Kazuhiko
    Banach, Maciej
    JOURNAL OF THORACIC DISEASE, 2017, 9 (01) : E78 - E82
  • [10] Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol lowering
    Norata, Giuseppe Danilo
    Tavori, Hagai
    Pirillo, Angela
    Fazio, Sergio
    Catapano, Alberico L.
    CARDIOVASCULAR RESEARCH, 2016, 112 (01) : 429 - 442
12345